Dr. Brian Ignatius Rebello , MD
Internal Medicine • Delray Beach, FL
13590 Jog Rd, Suite C3
Delray Beach, FL 334463807
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Brian Rebello is listed in NPPES under Internal Medicine.
-
NPI assigned on February 8, 2006; this date does not establish years in practice.
-
Published CMS data list 16,132 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 36415 — Insertion of needle into vein for collection of blood sample: 2,339 service units.
- 99213 — Established patient outpatient office visit: 2,088 service units.
- 99214 — Established patient outpatient office visit: 1,611 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 38 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 20,993 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 1,268 prescription fills, including refills.
- Levothyroxine Sodium — 1,055 prescription fills, including refills.
- Atorvastatin Calcium — 1,019 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 218 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Delray Beach, FL (2024, 56 clinicians with data). Median for this group: 2,128. Middle half: 612 to 5,195.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,821 clinicians with data). Median for this group: 689. Middle half: 278 to 1,488.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 14,539 in 2020 to 16,132 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
13590 Jog Rd
Suite C3
Delray Beach, FL 334463807
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Cora Health Services Inc; Rebello Medical Associates Md Pl. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
1988
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,438 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $855,639 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $633,095 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
50,347 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,717,236 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,978.35 across 53 records.
By nature of payment
- Food and Beverage: $1,978.35 across 53 records.
Reporting-company totals (3 largest of 18)
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.): $404.39 across 11 records.
- AstraZeneca Pharmaceuticals LP: $239.72 across 2 records.
- Novo Nordisk Inc: $214.43 across 8 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
38 years (graduated 1988)
CMS Doctors and Clinicians data list 1988 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Rebello has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Rebello as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Delray Beach and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Delray Beach, FL (2024, 56 clinicians with data). Median for this group: 2,128. Middle half: 612 to 5,195.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,821 clinicians with data). Median for this group: 689. Middle half: 278 to 1,488.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Internal Medicine in Delray Beach, FL (2024, 56 clinicians with data). Median for this group: $154,189. Middle half: $63,085 to $403,098.
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,821 clinicians with data). Median for this group: $68,400. Middle half: $27,804 to $138,071.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Internal Medicine in Delray Beach, FL (2024, 56 clinicians with data). Median for this group: $123,664. Middle half: $48,926 to $331,731.
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,821 clinicians with data). Median for this group: $52,790. Middle half: $20,913 to $107,263.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Delray Beach, FL (2024, 63 clinicians with data). Median for this group: 3,773. Middle half: 820 to 7,782.
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Florida (2024, 6,598 clinicians with data). Median for this group: 1,264. Middle half: 150 to 5,826.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Delray Beach, FL (2024, 63 clinicians with data). Median for this group: $289,617. Middle half: $50,493 to $645,030.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Florida (2024, 6,598 clinicians with data). Median for this group: $82,811. Middle half: $7,744 to $429,824.
98 active clinicians are listed under Internal Medicine with a practice address in Delray Beach, FL (10,334 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Delray Beach
33.7% of these 98 clinicians have the CMS telehealth indicator.
53.1% of these 98 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 11% from 14,539 in 2020 to 16,132 in 2024.
- 2020: 14,539
- 2021: 14,147
- 2022: 13,773
- 2023: 14,192
- 2024: 16,132
-
Medicare-allowed amount
Medicare-allowed amount decreased 12% from $969,466 in 2020 to $855,639 in 2024.
- 2020: $969,466
- 2021: $895,300
- 2022: $736,092
- 2023: $740,154
- 2024: $855,639
-
Paid by Medicare
Paid by Medicare decreased 18% from $767,732 in 2020 to $633,095 in 2024.
- 2020: $767,732
- 2021: $650,863
- 2022: $526,577
- 2023: $531,290
- 2024: $633,095
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 44% from 14,581 in 2020 to 20,993 in 2024.
- 2020: 14,581
- 2021: 17,183
- 2022: 17,599
- 2023: 20,062
- 2024: 20,993
-
30-day fills
30-day fills increased 41% from 35,601 in 2020 to 50,347 in 2024.
- 2020: 35,601
- 2021: 41,604
- 2022: 42,094
- 2023: 47,092
- 2024: 50,347
-
Part D drug cost
Part D drug cost increased 91% from $898,764 in 2020 to $1,717,236 in 2024.
- 2020: $898,764
- 2021: $1,102,488
- 2022: $1,067,233
- 2023: $1,436,544
- 2024: $1,717,236
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $982.18 in 2021 to $1,978.35 in 2025.
- 2021: $982.18
- 2022: $1,274.56
- 2023: $894.78
- 2024: $740.21
- 2025: $1,978.35
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 53 records totaling $1,978.35.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $127.64 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $123.75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $122.55 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $121.85 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $119.91 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $119.81 |
| Edwards Lifesciences Corporation |
Food and Beverage
In-kind items and services
|
— | General | $118.77 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $117.87 |
| Eli Lilly and Company |
Food and Beverage
Cash or cash equivalent
|
KISUNLA | General | $117.87 |
| Tactile Systems Technology Inc |
Food and Beverage
In-kind items and services
|
Flexitouch Plus | General | $44.10 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $31.90 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $30.30 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $29.18 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $28.93 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $28.02 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $26.54 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $26.44 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $25.10 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $24.60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $24.26 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SYNTHROID | General | $24.08 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
KEVEYIS | General | $23.00 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $22.98 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
KEVEYIS | General | $21.80 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $21.78 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
36415
Insertion of needle into vein for collection of blood sample
|
2,339 | 708 | $7.00 | $6.86 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
2,088 | 781 | $100.00 | $63.26 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,611 | 813 | $150.00 | $93.80 |
|
99308
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more
|
962 | 145 | $95.00 | $74.70 |
|
81002
Urinalysis, manual test
|
906 | 646 | $10.00 | $3.41 |
|
82274
Stool analysis for blood, by fecal hemoglobin determination by immunoassay
|
820 | 583 | $50.00 | $15.60 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
774 | 774 | $160.00 | $37.88 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
691 | 562 | $40.00 | $14.54 |
|
99497
Advance care planning, first 30 minutes
|
671 | 669 | $100.00 | $30.00 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
639 | 99 | $100.00 | $79.64 |
|
99441
Telephone medical discussion with physician, 5-10 minutes
|
633 | 387 | $65.00 | $56.34 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
631 | 149 | $150.00 | $119.77 |
|
G0008
Administration of influenza virus vaccine
|
536 | 535 | $30.00 | $29.40 |
|
90661
Influenza vaccine, trivalent derived from cell cultures
|
515 | 514 | $99.90 | $36.11 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
354 | 232 | $200.00 | $135.33 |
|
96372
Injection of drug or substance under skin or into muscle
|
272 | 91 | $30.00 | $14.29 |
|
J3420
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
|
267 | 88 | $20.00 | $1.24 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
243 | 169 | $300.00 | $174.49 |
|
99239
Hospital discharge day management, more than 30 minutes
|
209 | 143 | $150.00 | $115.08 |
|
99306
Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more
|
149 | 134 | $235.00 | $182.82 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
134 | 129 | $60.00 | $45.83 |
|
99496
Transitional care management services for problem of high complexity
|
119 | 104 | $300.00 | $123.06 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
101 | 101 | $300.00 | $223.90 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
73 | 14 | $30.00 | $42.69 |
|
G0180
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and
|
67 | 64 | $110.00 | $53.80 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1,268 | 109,419 | $16,636.74 | 378 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1,055 | 89,294 | $13,926.21 | 298 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1,019 | 85,423 | $10,585.22 | 298 |
| Amlodipine Besylate | Amlodipine Besylate | 956 | 80,933 | $6,875.55 | 285 |
| Alprazolam | Alprazolam | 706 | 31,329 | $5,676.57 | 198 |
| Losartan Potassium | Losartan Potassium | 689 | 60,142 | $8,421.28 | 201 |
| Omeprazole | Omeprazole | 433 | 37,006 | $6,028.42 | 137 |
| Pantoprazole Sodium | Pantoprazole Sodium | 416 | 35,008 | $6,760.81 | 140 |
| Escitalopram Oxalate | Escitalopram Oxalate | 380 | 29,914 | $5,841.68 | 112 |
| Azithromycin | Azithromycin | 371 | 1,954 | $1,480.82 | 294 |
| Gabapentin | Gabapentin | 364 | 24,530 | $5,774.51 | 128 |
| Metoprolol Succinate | Metoprolol Succinate | 342 | 28,850 | $5,777.17 | 107 |
| Methylprednisolone | Methylprednisolone | 333 | 2,061 | $2,171.57 | 263 |
| Simvastatin | Simvastatin | 314 | 26,552 | $2,896.86 | 94 |
| Lisinopril | Lisinopril | 305 | 26,175 | $2,457.40 | 90 |
| Famotidine | Famotidine | 295 | 24,349 | $6,265.48 | 111 |
| Metformin Hcl | Metformin Hcl | 293 | 23,760 | $2,044.74 | 83 |
| Zolpidem Tartrate | Zolpidem Tartrate | 256 | 18,341 | $4,081.55 | 104 |
| Sertraline Hcl | Sertraline Hcl | 249 | 20,406 | $2,199.32 | 66 |
| Tamsulosin Hcl | Tamsulosin Hcl | 246 | 20,434 | $4,400.39 | 85 |
| Trazodone Hcl | Trazodone Hcl | 246 | 19,603 | $2,467.65 | 86 |
| Potassium Chloride | Potassium Chloride | 244 | 16,200 | $9,363.93 | 83 |
| Furosemide | Furosemide | 231 | 15,359 | $993.83 | 86 |
| Montelukast Sodium | Montelukast Sodium | 222 | 19,196 | $3,159.52 | 68 |
| Eliquis | Apixaban | 208 | 12,694 | $235,791.98 | 69 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-01-05NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20040916000410
FL
6103893706
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Cora Health Services Inc
7015 Beracasa Way, Boca Raton, FL 334333453
Phone: 5619392033
Rebello Medical Associates Md Pl
13590 S Jog Rd, Delray Beach, FL 334463807
Phone: 5616378383
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 13590 S JOG RD STE 3C, DELRAY BEACH, FL 334463807 (Tel: 5616378383)
NPI status registered as active in NPPES database
Registered at 13590 JOG RD, SUITE C3, DELRAY BEACH, FL 334463807 (Tel: 5616378383)
Registered at PO BOX 7929, DELRAY BEACH, FL 334827929 (Tel: 5616378383)
Recorded as BRIAN REBELLO, M.D.
Internal Medicine (license number reported to NPPES: FL ME0077666)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Delray Beach
- Dr. Kenneth Mandell, MD
- Dr. Audrey Liu, MD
- Dr. Samuel Ganz, DO
- Dr. Alexa Constantakos, DO
- Dr. Joanna Widdows, DO
- Dr. Bruce Berenson, MD
Mailing Address
13590 S Jog Rd Ste 3c
Delray Beach, FL 334463807
Phone: 5616378383